TotalMarketCap

Pluri

PLURNasdaq IsraelHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$17.080 M

$1.19 -3.26%

Close of 6 Nov 2026

As of 6 Nov 2026, Pluri (PLUR) has a market capitalization of $17.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.34M

#3434 by revenue

Earnings

-$22.6M

Loss-making

Shares outstanding

12,344,736

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #139Black Hawk AcquisitionBKHA$18.7M
  2. #140Estrella ImmunopharmaESLA$17.6M
  3. #141PluriPLUR$17.1M
  4. #142Jasper TherapeuticsJSPR$15.6M
  5. #143Acumen PharmaceuticalsABOS$15.4M

What if Pluri were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,967,211

Per share 1,653,257× higher

Bitcoin $1.53T

$106,442.35

Per share 89,455× higher

Apple $5.02T

$349,440.31

Per share 293,672× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Pluri are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.